REM Sleep without atonia correlates with abnormal vestibular-evoked myogenic potentials in isolated REM sleep behavior disorder.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
06 09 2019
Historique:
received: 30 01 2019
revised: 14 04 2019
pubmed: 17 7 2019
medline: 9 7 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

The neurophysiological hallmark of REM sleep behavior disorder (RBD) is loss of atonia during REM sleep. Indeed, signs and symptoms of neurodegeneration can occur after years, even decades, from its beginning. This study aimed to measure neurophysiological alterations of the brainstem that potentially correlate with the severity of atonia loss, and determining whether a prodromal neurodegenerative disorder underlines this condition when it occurs as an isolated condition (iRBD). Subjects with iRBD and matched healthy controls were recruited. The study included the recording of one-night polysomnography, vestibular-evoked myogenic potentials (VEMPs), and a [123I]-FP-CIT dopamine transporter (DAT) scan. The quantification of REM sleep without atonia (RSWA) was made according to two previously published manual methods and one automated method. The rate of alteration of VEMPs and VEMP score were significantly higher in iRBD patients than controls. Moreover, VEMP score was negatively correlated with the automated REM atonia index; a marginal statistical significance was also reached for the positive correlation with the visual tonic electromyographic parameter, while the other correlations, including that with DAT-scan score were not statistically significant. Brainstem neurophysiology in iRBD can be assessed by VEMPs and their alterations may possibly indicate an early expression of the neurodegenerative process underlying this disorder at the brainstem level, which awaits future longitudinal confirmation. The correlation between RSWA and VEMP alteration might also represent a prodromal aspect anticipating the possible evolution from iRBD to neurodegeneration, whereas DAT-scan abnormalities might represent a later step in this evolution.

Identifiants

pubmed: 31310647
pii: 5532726
doi: 10.1093/sleep/zsz128
pii:
doi:

Substances chimiques

Tropanes 0
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 155797-99-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Auteurs

Monica Puligheddu (M)

Sleep Disorder Research Center, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Michela Figorilli (M)

Sleep Disorder Research Center, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Alessandra Serra (A)

Nuclear Medicine Unit, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Ilaria Laccu (I)

Sleep Disorder Research Center, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Patrizia Congiu (P)

Sleep Disorder Research Center, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Ludovica Tamburrino (L)

Sleep Disorder Research Center, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Edoardo Rosario de Natale (ER)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Francesca Ginatempo (F)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Franca Deriu (F)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Gianluigi Loi (G)

Nuclear Medicine Unit, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Maria Livia Fantini (ML)

EEG and Sleep Unit, Neurology Department, CHU Clermont Ferrand, University of Clermont Auvergne, Clermont-Ferrand, France.

Carlos H Schenck (CH)

Minnesota Regional Sleep Disorders Center and Departments of Psychiatry, Hennepin County Medical Center and University of Minnesota Medical School, Minneapolis, MN.

Raffaele Ferri (R)

Sleep Research Centre, Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH